Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter Meersseman

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Journal of Clinical Microbiology|February 4, 2012
Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validityJorien D'Haese, Koen Theunissen, Edith Vermeulen, et al.
Intensive Care Medicine|August 17, 2012
Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective studyJoost Wauters, Ingrid Baar, Philippe Meersseman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2009
Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseasesJohan Maertens, Vincent Maertens, Koen Theunissen, et al.
Critical Care Medicine|September 20, 2011
Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patientsGreet De Vlieger, Wouter Meersseman, Katrien Lagrou, et al.
The New England Journal of Medicine|February 3, 2006
Intensive insulin therapy in the medical ICUGreet Van den Berghe, Alexander Wilmer, Greet Hermans, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2010
Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantationStef Meers, Katrien Lagrou, Koen Theunissen, et al.
Journal of Clinical Microbiology|October 23, 2009
Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancyStefanie Desmet, Eric Van Wijngaerden, Johan Maertens, et al.
International Journal of Antimicrobial Agents|December 10, 2013
Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohortHerbert Spapen, Jerrold Spapen, Fabio S Taccone, et al.
Anaesthesiology Intensive Therapy|August 1, 2014
Prognostic value of serum galactomannan in mixed ICU patients: a retrospective observational studySuzanne Teering, Annelies Verreth, Anneleen Peeters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2007
Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassayJohan A Maertens, Rocus Klont, Christine Masson, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Microbiology|February 4, 2012
Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validityJorien D'Haese, Koen Theunissen, Edith Vermeulen, et al.
Intensive Care Medicine|August 17, 2012
Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective studyJoost Wauters, Ingrid Baar, Philippe Meersseman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2009
Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseasesJohan Maertens, Vincent Maertens, Koen Theunissen, et al.
Critical Care Medicine|September 20, 2011
Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patientsGreet De Vlieger, Wouter Meersseman, Katrien Lagrou, et al.
The New England Journal of Medicine|February 3, 2006
Intensive insulin therapy in the medical ICUGreet Van den Berghe, Alexander Wilmer, Greet Hermans, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2010
Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantationStef Meers, Katrien Lagrou, Koen Theunissen, et al.
Journal of Clinical Microbiology|October 23, 2009
Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancyStefanie Desmet, Eric Van Wijngaerden, Johan Maertens, et al.
International Journal of Antimicrobial Agents|December 10, 2013
Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohortHerbert Spapen, Jerrold Spapen, Fabio S Taccone, et al.
Anaesthesiology Intensive Therapy|August 1, 2014
Prognostic value of serum galactomannan in mixed ICU patients: a retrospective observational studySuzanne Teering, Annelies Verreth, Anneleen Peeters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2007
Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassayJohan A Maertens, Rocus Klont, Christine Masson, et al.
Pageof 8